Clinical Trial Update: Efficiency of Placental Drug Melsmon® in Correction of Climacteric Symptoms in Premenopausal Women [Phase 2, Phase 3]

View source ↗

Summary

The document reports the completed Phase 2/Phase 3 clinical trials evaluating the effectiveness of Melsmon placental extract in correcting climacteric symptoms …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Climacteric Syndrome

Drugs mentioned

• Melsmon (placental extract)

Snippet

Sponsor: Inna I. Kovalenko | Conditions: Climacteric Syndrome | Phase 2, Phase 3 | Status: COMPLETED